Who invested in Laigo Bio

2 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechFood & BeverageHealthcare

Raised 7 months ago

Funding summaryUpdated 26 Oct 2026

$20Mraised across 2 rounds since 2025, from 3 sources

$13MSeed$6.4MSeed

Latest round: Seed, $6.4MApr 2026
Led by: KurmaPartners and Biovance Capital
Biggest round: $13MSeed · Dec 2025
Investors: 9 (3 led)

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026

$13MSeed$6.4MSeed

First round: Seed, $13M
Biggest round: $13M
Between rounds: 4 months

The rounds

Apr 2026
Seed$6.4M1 new8 returning
Reported by Biovance Capital and 1 other
Dec 2025
Seed$13M8 new
Reported by Curie Capital

Founders and team

From Laigo Bio's own website: 2 founders, 3 on the team.

Madelon MauriceScientific founder

Neill Moray MackenzieCo-founder & Chair

Matthew BakerCEO
Maureen SpitVP, Research
Aisha KrishnaDirector of Operations

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2025Seed2026

Cancer Research Horizons

Argobio StudioOncode Bridge Fund

Biovance CapitalL

Everyone who backed them

KurmaPartnersVC firm2rounds, led 2

Curie CapitalVC firm2rounds, led 1

EurazeoPrivate equity2rounds

Angelini VenturesVC firm2rounds

ROM Utrecht RegionVC firm2rounds

Cancer Research HorizonsVC firm2rounds

Argobio StudioVenture studio2rounds

Oncode Bridge FundVC firm2rounds

Biovance CapitalVC firm1round, led 1

Missing a round, or an investor who was in one? Tell us.

Quick answers about Laigo Bio

Who invested in Laigo Bio?

Laigo Bio's investors include KurmaPartners, Curie Capital, Eurazeo, Angelini Ventures and ROM Utrecht Region, and 4 more on record. KurmaPartners led its latest round.